UBS Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,926
| Closed | -$3.05K | – | 8993 |
|
|
2023
Q4 | $3.05K | Buy |
13,926
+13,841
| +16,284% | +$3.03K | ﹤0.01% | 6804 |
|
|
2023
Q3 | $27 | Sell |
85
-85
| -50% | -$27 | ﹤0.01% | 7942 |
|
|
2023
Q2 | $158 | Buy |
170
+85
| +100% | +$79 | ﹤0.01% | 7353 |
|
|
2023
Q1 | $76 | Sell |
85
-5,063
| -98% | -$4.53K | ﹤0.01% | 8180 |
|
|
2022
Q4 | $8.85K | Sell |
5,148
-582
| -10% | -$1K | ﹤0.01% | 7525 |
|
|
2022
Q3 | $12K | Buy |
5,730
+5,645
| +6,641% | +$11.8K | ﹤0.01% | 7114 |
|
|
2022
Q2 | $0 | Hold |
85
| – | – | ﹤0.01% | 10025 |
|
|
2022
Q1 | $0 | Sell |
85
-924
| -92% | – | ﹤0.01% | 9852 |
|
|
2021
Q4 | $4K | Buy |
1,009
+924
| +1,087% | +$3.66K | ﹤0.01% | 8452 |
|
|
2021
Q3 | $1K | Hold |
85
| – | – | ﹤0.01% | 8148 |
|
|
2021
Q2 | $1K | Sell |
85
-513
| -86% | -$6.04K | ﹤0.01% | 8113 |
|
|
2021
Q1 | $5K | Sell |
598
-3,585
| -86% | -$30K | ﹤0.01% | 7314 |
|
|
2020
Q4 | $16K | Buy |
+4,183
| New | +$16K | ﹤0.01% | 6109 |
|
|
2020
Q3 | – | Sell |
-2,320
| Closed | -$21K | – | 7495 |
|
|
2020
Q2 | $21K | Sell |
2,320
-2,723
| -54% | -$24.6K | ﹤0.01% | 5689 |
|
|
2020
Q1 | $30K | Buy |
+5,043
| New | +$30K | ﹤0.01% | 5319 |
|
|
2019
Q4 | – | Sell |
-78
| Closed | -$1K | – | 7255 |
|
|
2019
Q3 | $1K | Buy |
+78
| New | +$1K | ﹤0.01% | 6898 |
|
|
2019
Q2 | – | Sell |
-1,046
| Closed | -$11K | – | 7206 |
|
|
2019
Q1 | $11K | Buy |
1,046
+788
| +305% | +$8.29K | ﹤0.01% | 5932 |
|
|
2018
Q4 | $2K | Sell |
258
-24
| -9% | -$186 | ﹤0.01% | 6892 |
|
|
2018
Q3 | $7K | Buy |
+282
| New | +$7K | ﹤0.01% | 6430 |
|
|
2018
Q2 | – | Sell |
-311
| Closed | -$14K | – | 7216 |
|
|
2018
Q1 | $14K | Buy |
+311
| New | +$14K | ﹤0.01% | 5794 |
|